Report: Clinical Decision Support Market to Reach $4.97B by 2021 | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Report: Clinical Decision Support Market to Reach $4.97B by 2021

July 19, 2017
by Rajiv Leventhal
| Reprints

A changing healthcare landscape that includes a shift to value-based reimbursement will transform the clinical decision support systems (CDSS) market in the U.S., according to a report from Frost & Sullivan.

The report noted that the advent of meaningful use and changing documentation requirements to achieve reimbursement are creating a complex and connected CDS infrastructure that includes digital workflow, electronic health records (EHRs) and point-of-care solutions.

EHRs are expected to be the hub for CDSS as growing volumes of patient data from a variety of sources will encourage workflow improvements to enable patient surveillance at the point-of-care.  These systems will further evolve to include the pool of patient data needed to develop predictive analytics and enhance the performance of population health systems, the report stated.

As such, researchers have predicted that the overall U.S. CDSS market is expected to be worth $4.97 billion in 2021. “The introduction of value-based reimbursements and quality performance measures will increase the value of evidence-based data to document a clinical rationale and support medical decision making," Digital Health Principal Analyst Victor Camlek said in a statement. "Essentially, the CDSS market will comprise a wide array of companies, ranging from established clinical content providers to vendors of medical devices, analytical services, and workflow tools. This emerging ecosystem will encourage alliances and merger/acquisition activity, and underscore the necessity for a dedicated CDSS infrastructure vital to improving patient outcomes,” he said.

Indeed, key growth opportunities for the market will involve:

  • Enhancing EHRs by including CDS data and working toward fully interoperable EHRs;
  • Extending CDSS to population health systems by feeding in actionable data;
  • Refining and advancing clinical surveillance technology; and
  • Including access to patients who will benefit from the ability to retrieve accurate and relevant data pertaining to their medical condition that will encourage improved adherence and outcomes.

"The challenge will be to make CDSS a resource that is appropriate for all stakeholders that is compliant with privacy and security guidelines, and flexible enough to function in a constantly evolving healthcare regulatory environment," added Camlek.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Cedars-Sinai Collaborates on Organs-on-Chip Precision Medicine Project

Scientists at Los Angeles-based Cedars-Sinai, in partnership with biotechnology startup Emulate, are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant.

Blockchain Company Hashed Health Gets New Partner

ODH, Inc., a New Jersey-based health technology company, has joined with blockchain innovation consortium Hashed Health.

NCQA Approved by Government as ONC-Authorized Testing Lab

The National Committee for Quality Assurance (NCQA) has announced that its eMeasure testing laboratory is now approved by the Office of the National Coordinator for Health Information Technology (ONC).

Survey: Infrastructure, Interoperability Key Barriers to Global HIT Development

A new survey report from Black Book Research on global healthcare IT adoption and records systems connectivity finds nations in various phases of regional electronic health record (EHR) adoption. The survey results also reveal rapidly advancing opportunities for U.S.-based and local technology vendors.

Penn Medicine Opens Up Telehealth Hub

Philadelphia-based Penn Medicine has opened its Center for Connected Care to centralize the health system’s telemedicine activities.

Roche to Pay $1.9B for Flatiron Health

Switzerland-based pharmaceutical company Roche has agreed to pay $1.9 billion to buy New York-based Flatiron Health Inc., which has both an oncology EHR and data analytics platform.